StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Neuland Laboratories Limited
NSE:NEULANDLAB.NS
Sector
Location
Market Cap
USD 2.12 B
Share Price
USD 165.51
Avg Daily Volume
57,339
Change (1 day)
-1.75%
Change (1 year)
63.41%
Change (YTD)
3.23%
Neuland Laboratories Limited Share Price Year-To-Date (YTD) return on July 18, 2025: 3.23%
Neuland Laboratories Limited Share Price Year-To-Date (YTD) return is 3.23% on July 18, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.
-
Neuland Laboratories Limited 52-week low Share Price is USD 210.66 on July 18, 2025, which is 27.28% above the current Share Price.
-
Neuland Laboratories Limited 52-week low Share Price is USD 95.71 on July 18, 2025, which is -42.17% below the current Share Price.
-
Neuland Laboratories Limited average Share Price for the last 52 weeks is USD 150.34.
Competitors
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Cencora, Inc.
USD 292.87
COR
-1.51
-0.51%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Haleon plc
USD 4.81
HLN.L
-0.00
-0.08%
Daiichi Sankyo Company, Limited
USD 24.17
4568.T
+0.03
0.11%
Ucb S.A.
USD 203.26
UCB.BR
+1.51
0.75%
BeOne Medicines Ltd.
USD 294.55
ONC
+4.20
1.45%
Key Data
| Date | Share Price Year-To-Date (YTD) return | Price to Earnings Ratio (P/E) | Price to Book Ratio (P/B) | Price to Sales Ratio (P/S) |
|---|
Competitors
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Cencora, Inc.
USD 292.87
COR
-1.51
-0.51%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Haleon plc
USD 4.81
HLN.L
-0.00
-0.08%
Daiichi Sankyo Company, Limited
USD 24.17
4568.T
+0.03
0.11%
Ucb S.A.
USD 203.26
UCB.BR
+1.51
0.75%
BeOne Medicines Ltd.
USD 294.55
ONC
+4.20
1.45%